J. Goldman & Co’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.2M | Buy |
+243,448
| New | +$7.2M | 0.17% | 125 |
|
|
2021
Q3 | – | Sell |
-96,347
| Closed | -$2.28M | – | 263 |
|
|
2021
Q2 | $2.28M | Buy |
96,347
+19,790
| +26% | +$468K | 0.09% | 167 |
|
|
2021
Q1 | $1.81M | Sell |
76,557
-69,208
| -47% | -$1.64M | 0.06% | 183 |
|
|
2020
Q4 | $2.92M | Buy |
145,765
+76,401
| +110% | +$1.53M | 0.15% | 118 |
|
|
2020
Q3 | $1.44M | Sell |
69,364
-148,590
| -68% | -$3.09M | 0.1% | 137 |
|
|
2020
Q2 | $3.81M | Sell |
217,954
-156,588
| -42% | -$2.74M | 0.24% | 84 |
|
|
2020
Q1 | $6.12M | Buy |
374,542
+259,640
| +226% | +$4.24M | 0.74% | 22 |
|
|
2019
Q4 | $2.37M | Sell |
114,902
-20,297
| -15% | -$418K | 0.17% | 86 |
|
|
2019
Q3 | $1.55M | Buy |
135,199
+100,200
| +286% | +$1.15M | 0.12% | 96 |
|
|
2019
Q2 | $460K | Sell |
34,999
-200,016
| -85% | -$2.63M | 0.03% | 135 |
|
|
2019
Q1 | $3.56M | Sell |
235,015
-831,832
| -78% | -$12.6M | 0.2% | 86 |
|
|
2018
Q4 | $18.3M | Sell |
1,066,847
-515,038
| -33% | -$8.84M | 1.41% | 6 |
|
|
2018
Q3 | $23.3M | Buy |
1,581,885
+1,301,375
| +464% | +$19.2M | 1.63% | 7 |
|
|
2018
Q2 | $6.69M | Buy |
280,510
+56,486
| +25% | +$1.35M | 0.35% | 52 |
|
|
2018
Q1 | $5.72M | Buy |
+224,024
| New | +$5.72M | 0.24% | 67 |
|
|
2017
Q4 | – | Sell |
-522,593
| Closed | -$5.48M | – | 237 |
|
|
2017
Q3 | $5.48M | Buy |
522,593
+211,593
| +68% | +$2.22M | 0.28% | 57 |
|
|
2017
Q2 | $3.89M | Sell |
311,000
-33,129
| -10% | -$414K | 0.21% | 68 |
|
|
2017
Q1 | $3.46M | Buy |
344,129
+119,279
| +53% | +$1.2M | 0.17% | 93 |
|
|
2016
Q4 | $3.5M | Buy |
224,850
+146,850
| +188% | +$2.29M | 0.23% | 73 |
|
|
2016
Q3 | $1.5M | Sell |
78,000
-21,000
| -21% | -$404K | 0.08% | 122 |
|
|
2016
Q2 | $1.17M | Buy |
+99,000
| New | +$1.17M | 0.06% | 130 |
|